These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11361222)

  • 21. Double mutant MRL-lpr/lpr-gld/gld cells fail to trigger lpr-graft-versus-host disease in syngeneic wild-type recipient mice, but can induce wild-type B cells to make autoantibody.
    Zhu B; Beaudette BC; Rifkin IR; Marshak-Rothstein A
    Eur J Immunol; 2000 Jun; 30(6):1778-84. PubMed ID: 10898516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera.
    Matsuno H; Yudoh K; Nakazawa F; Sawai T; Uzuki M; Nishioka K; Yonehara S; Nakayama J; Ohtsuki M; Kimura T
    J Rheumatol; 2002 Aug; 29(8):1609-14. PubMed ID: 12180717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of Fas ligand as an effector molecule in corneal graft rejection.
    Stuart PM; Yin X; Plambeck S; Pan F; Ferguson TA
    Eur J Immunol; 2005 Sep; 35(9):2591-7. PubMed ID: 16114107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells.
    Modiano JF; Sun J; Lang J; Vacano G; Patterson D; Chan D; Franzusoff A; Gianani R; Meech SJ; Duke R; Bellgrau D
    Clin Immunol; 2004 Jul; 112(1):54-65. PubMed ID: 15207782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-CD3 induces bi-phasic apoptosis in murine intestinal epithelial cells: possible involvement of the Fas/Fas ligand system in different T cell compartments.
    Miura N; Yamamoto M; Fukutake M; Ohtake N; Iizuka S; Ishige A; Sasaki H; Fukuda K; Yamamoto T; Hayakawa S
    Int Immunol; 2005 May; 17(5):513-22. PubMed ID: 15778290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of wasting syndrome in [MRL lpr/lpr-->MRL +/+] chimera and graft versus host disease in [B10.D2-->BALB/c] chimera and an attempt to transfer the wasting syndrome in [MRL lpr/lpr-->MRL +/+] to MRL +/+ mice.
    Aihara M; Aihara Y; Nakajima H
    J Dermatol Sci; 1994 Apr; 7(2):107-18. PubMed ID: 7914743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell dependent and independent antitumor immunity generated by the expression of Fas ligand on mouse lung carcinoma cells.
    Tada Y; O-Wang J; Takiguchi Y; Tatsumi K; Kuriyama T; Tagawa M
    Int J Mol Med; 2002 Mar; 9(3):281-5. PubMed ID: 11836634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
    Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A
    Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fas ligand enhances hematopoietic cell engraftment through abrogation of alloimmune responses and nonimmunogenic interactions.
    Pearl-Yafe M; Yolcu ES; Stein J; Kaplan O; Yaniv I; Shirwan H; Askenasy N
    Stem Cells; 2007 Jun; 25(6):1448-55. PubMed ID: 17363551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytolytic capabilities of lamina propria and intraepithelial lymphocytes in normal and chronically inflamed human intestine.
    Melgar S; Hammarström S; Oberg A; Danielsson A; Hammarström ML
    Scand J Immunol; 2004; 60(1-2):167-77. PubMed ID: 15238086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ex vivo soluble fas ligand treatment of donor cells to selectively reduce murine acute graft versus host disease.
    Georgantas RW; Bohana-Kashtan O; Civin CI
    Transplantation; 2006 Aug; 82(4):471-8. PubMed ID: 16926590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
    Miura Y; Thoburn CJ; Bright EC; Hess AD
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Fas/Fas ligand-mediated apoptosis in murine contact hypersensitivity.
    Xu B; Bulfone-Paus S; Aoyama K; Yu S; Huang P; Morimoto K; Matsushita T; Takeuchi T
    Int Immunopharmacol; 2003 Jul; 3(7):927-38. PubMed ID: 12810350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
    Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.
    Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M
    Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crucial Fas-Fas ligand interaction in spontaneous acceptance of hepatic allografts in mice.
    Uchiyama H; Kishihara K; Minagawa R; Hashimoto K; Sugimachi K; Nomoto K
    Immunology; 2002 Apr; 105(4):450-7. PubMed ID: 11985665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CTLA-4.FasL inhibits allogeneic responses in vivo.
    Dranitzki-Elhalel M; Huang JH; Rachmilewitz J; Pappo O; Parnas M; Schmidt W; Tykocinski ML
    Cell Immunol; 2006 Feb; 239(2):129-35. PubMed ID: 16828466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of apoptosis and interferon-gamma in murine toxoplasmosis.
    Shen DF; Matteson DM; Tuaillon N; Suedekum BK; Buggage RR; Chan CC
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2031-6. PubMed ID: 11481268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fas receptor signaling is requisite for B cell differentiation.
    Pasqualetto V; Vasseur F; Zavala F; Schneider E; Ezine S
    J Leukoc Biol; 2005 Nov; 78(5):1106-17. PubMed ID: 16266974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family.
    Di Renzo M; Rubegni P; Sbano P; Cuccia A; Castagnini C; Pompella G; Pasqui AL; Capecchi PL; Auteri A; Laghi Pasini F; Fimiani M
    Arch Dermatol Res; 2003 Sep; 295(5):175-82. PubMed ID: 12883827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.